Table 3 Percentage of infants positive for IgM antibodies at their first sub-microscopic and slide-positive infections, as well as at the first symptomatic clinical episode
Antigens | Sub-microscopic infectiona (n = 18) | Slide positive infectionsb (n = 39) | First clinical episode (n = 11) |
|---|---|---|---|
AMA-1 (3D7) | 44.4 | 76.9 | 73 |
AMA-1 (FV0) | 33.3 | 82.1 | 91 |
EBA-175 | 27.8 | 66.7 | 73 |
MSP-1 (3D7) | 22.2 | 76.9 | 91 |
MSP-1 (FVO) | 33.3 | 79.5 | 91 |
MSP-2 (3D7) | 27.8 | 79.5 | 91 |
MSP2 (FC27) | 27.8 | 74.4 | 82 |
MSP-3 | 11.1 | 59.0 | 91 |
RESA | 11.1 | 71.8 | 64 |
LSA-1 | 16.7 | 74.4 | 91 |
CSP | 22.2 | 69.2 | 82 |